Clinical Trials Directory

Trials / Completed

CompletedNCT06858423

Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients

Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in the Treatment of Adult Patients With Allergic Rhinitis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
360 (actual)
Sponsor
Benha University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Budesonide is a medication of the corticosteroid type. Available as an inhaler, nebulization solution, The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease is used for allergic rhinitis and nasal polyps fluticasone propionate

Detailed description

The current study aims to compare between results of budesonid nasal irrigation and fluticasone nasal spray in the treatment of adult patients with Allergic Rhinitis.

Conditions

Interventions

TypeNameDescription
DRUGBudesonide buffered with 0.9% isotonic saline.120 patients received budesonide buffered with 0.9% isotonic saline.
DRUGFluticasone propionate nasal spray.120 patients received fluticasone propionate nasal spray.
OTHER0.9% saline for nasal irrigation.120 patients used 0.9% saline for nasal irrigation.

Timeline

Start date
2023-08-15
Primary completion
2024-03-31
Completion
2024-05-31
First posted
2025-03-05
Last updated
2025-03-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06858423. Inclusion in this directory is not an endorsement.